gip/glp-1 receptor agonist drugs list GI Adverse Effects of Glucagon-Like Peptide-1 Agonists GIPR/GLP-1R dual agonist therapies for

YZ participated in topic design, manuscript writing, manuscript editing and providing instructional support

When treating diseases such as high blood pressure or hyperlipidemia with drugs, we do not expect a cure, but we expect relief and are concerned about recurrence when drug treatment for these diseases is discontinued

Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes

Each of the three pathways contributes different effects: GI Side Effects (Primarily from GLP-1) The GLP-1 component is responsible for most gastrointestinal side effects because it slows gastric emptying and affects gut motility: Metabolic Effects (From Glucagon Component) The glucagon component may cause slight increases in: Heart rate: Average increase of 5-10 bpm due to increased metabolic rate (similar to tirzepatide) Body temperature: Some users report feeling warmer, especially after meals (thermogenesis) Energy levels: Variable

By 2030, the market is set to reach $33.26 billion, maintaining a CAGR of 8.6%

The TRIUMPH-5 study will provide data for a direct comparison between tirzepatide and retatrutide for WL